Vancouver, July 8, 2021– Andira Pharmaceuticals (“Andira”) has been awarded two consecutive Mitacs Accelerate Internship grants to advance anti-infective R&D within the Prof. Charles Thompson Laboratory at the University of…
Vancouver, July 7, 2021– Andira Pharmaceuticals today announces it has secured an exclusive worldwide license for a portfolio of three cannabinoid antibiotic technologies along with their complementary drug delivery systems…
For media, investors room, further information or other inquiries, please contact us here:
Subscribe to our mailing list to receive Andira news releases.
Copyright © 2024 Andira Pharmaceuticals
